[Federal Register Volume 64, Number 154 (Wednesday, August 11, 1999)]
[Notices]
[Page 43884]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-20645]



[[Page 43883]]

_______________________________________________________________________

Part VI





Department of Health and Human Services





_______________________________________________________________________



National Institutes of Health



_______________________________________________________________________



Recombinant DNA Advisory Committee and Office of Recombinant DNA 
Activities; Notice of Meeting and Proposed Actions Under the NIH 
Guidelines; Notice

  Federal Register / Vol. 64, No. 154 / Wednesday, August 11, 1999 / 
Notices  

[[Page 43884]]



DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Recombinant DNA Advisory Committee; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given of a meeting 
of the Recombinant DNA Advisory Committee on September 2-3, 1999. The 
meeting will be held at the National Institutes of Health, Building 
31C, 6th Floor, Conference Room 10, 9000 Rockville Pike, Bethesda, 
Maryland 20892, starting on September 2, 1999, at approximately 9:00 
a.m., and will recess at approximately 5:00 p.m. The meeting will 
reconvene on September 3, 1999, at approximately 8:30 a.m. and will 
adjourn at approximately 5:00 p.m. The meeting will be held to discuss 
Proposed Actions under the NIH Guidelines for Research Involving 
Recombinant DNA Molecules (59 FR 34496) and other matters to be 
considered by the Committee. The Proposed Actions will follow this 
notice of meeting. The meeting will be open to the public. Attendance 
by the public will be limited to space available.
    Debra W. Knorr, Deputy Director, Office of Recombinant DNA 
Activities, National Institutes of Health, MSC 7010, 6000 Executive 
Boulevard, Suite 302, Bethesda, Maryland 20892-7010, Phone (301) 496-
9838, FAX (301) 496-9839, will provide a summary of the meeting and a 
roster of committee members upon request. Individuals who plan to 
attend and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should contact Ms. 
Knorr in advance of the meeting. The Office of Recombinant DNA 
Activities (ORDA) web site is located at http://www.nih.gov/od/orda for 
further information about the office.
    OMB's ``Mandatory Information Requirements for Federal Assistance 
Program Announcements'' (45 FR 39592, June 11, 1980) requires a 
statement concerning the official government programs contained in the 
Catalog of Federal Domestic Assistance. Normally NIH lists in its 
announcements the number and title of affected individual programs for 
the guidance of the public. Because the guidance in this notice covers 
virtually every NIH and Federal research program in which DNA 
recombinant molecule techniques could be used, it has been determined 
not to be cost effective or in the public interest to attempt to list 
these programs. Such a list would likely require several additional 
pages. In addition, NIH could not be certain that every Federal program 
would be included as many Federal agencies, as well as private 
organizations, both national and international, have elected to follow 
the NIH Guidelines. In lieu of the individual program listing, NIH 
invites readers to direct questions to the information address above 
about whether individual programs listed in the Catalog of Federal 
Domestic Assistance are affected.

    Dated: July 27, 1999.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy, NIH.
[FR Doc. 99-20645 Filed 8-10-99; 8:45 am]
BILLING CODE 4140-01-P